Material Safety Data Sheet ST9512 MICR Toner Cartridge

Material Safety Data Sheet ST9512 MICR Toner Cartridge
Material Safety Data Sheet
ST9512 MICR Toner Cartridge
Section 1 - Chemical Products & Company Identification
Name: MICR Toner
Chemical Family: Thermoplastic Powder (MICR)
Manufacturer’s Name: Source Technologies, LLC.
Address: 2910 Whitehall Park Dr., Charlotte, NC 28273
Telephone: 704-969-7500
P/N: STI-204512 (24B1408)
Product Use: Print Cartridge
Section 2 - Composition/Information on Ingredients
Component
Styrene Acrylate Copolymer
Iron Oxides
Percent (Wt.)
45-60
25-40
CAS #
58048-89-8
1317-61-9
Osha Pel
None
None
Iron Oxides
1-15
1309-37-1
10 mg/m TWA
1-4
Trade Secret
None
None
1-4
Trade Secret
None
None
Copolymer
NJTSRN 80100451-5022
Styrene Acrylic Copolymer
NJTSRN 80100451-5029
3
Acgih Tlv
None
None
3
5 mg/m TWA (as Fe,
welding fumes, dust, total
particulate)
Section 3 - Hazards Identification
The following information is based on data obtained from testing of the toner contained in this product and on the characteristics of toner component
chemicals.
Primary Routes of Entry: Inhalation of toner dust, skin contact
Signs and Symptoms of Exposure: Large amounts of toner on skin or mucus membranes (mouth, eyes & nose) may cause discomfort.
Medical Conditions Aggravated by Exposure: None known. Exposures to high airborne dust concentrations, including toner, may aggravate existing
respiratory conditions.
Physical Hazards: As with most finely divided dusts, explosion is possible when extremely high concentrations of dust and an ignition source are
present. Not a hazard when using adequate workplace controls.
Potential Health Effects
Inhalation:
Short Term Exposure - As with exposure to high concentrations of any dust, minimal respiratory tract irritation may occur if excessive amounts of toner
dust are inhaled.
Long Term Exposure - Chronic inhalation exposure to excessive concentrations of iron oxide-containing dusts has resulted in an often asymptomatic
condition identified as siderosis, a relatively benign pneumoconiosis, cause by deposition of iron oxide particles in the lung.
Skin Contact:
Short Term Exposure - Toner is not a skin irritant and has low dermal toxicity.
Long Term Exposure - Rare individuals may note skin rash with repeated contact.
Eye Contact:
Short Term Exposure - Toner may act as a mechanical irritant.
Long Term Exposure - No adverse chronic effects known.
Ingestion:
Short Term Exposure - Test data indicates toner is of low acute oral toxicity. Swallowing excessive amounts of pure iron oxide can cause the same toxic
effects caused by swallowing excessive amounts of any insoluble iron salt or iron dietary supplement. Initial symptoms include abdominal pain, seizures,
and increased heart and breathing rates. Exposure not probable with intended use.
Long Term Exposure - Toner is not expected to be chronically toxic. Chronic exposure to high doses of pure iron oxide has caused cardiovascular, liver,
and blood component effects. Exposure not probable with intended use.
Section 4 - First Aid Measures
Inhalation: Remove to fresh air. Seek medical attention if breathing becomes difficult.
Skin Contact: Wash affected area with soap and water. Seek medical attention if irritation develops and persists.
Eye Contact: Do not rub eyes. Flush immediately with plenty of water. Remove contact lenses and continue flushing for at least 15 minutes. Seek medical
attention if irritation develops and persists.
Ingestion: Immediately rinse mouth out with plenty of water. Within 30 minutes of ingestion, give victim a small glass of water or milk (NEVER give anything
by mouth to an unconscious person). If a large amount of toner has been ingested, contact physician or poison center. Do not induce vomiting unless
instructed to do so by a physician or poison center.
Section 5 - Fire Fighting Measures
Flash Point: Not applicable
Autoignition: Not applicable
Flammability Limits (%): Not applicable
Extinguishing Media: Water, foam, carbon dioxide or dry chemical
Fire and Explosion Hazard: No unusual fire or explosion hazards are
known for this product.
Fire Fighting: Fire may produce small amounts of hazardous
decomposition products such as carbon dioxide, carbon monoxide, and
unidentified organics. NIOSH approved self-contained breathing
apparatus may be required if large volume of toner is involved.
Hazardous Combustion Products: Carbon monoxide, carbon dioxide,
low molecular weight organics.
STI-204512
Revised 11/06
Material Safety Data Sheet
Section 6 - Accidental Release Measures
Occupational Spill: If a dust cloud is present due to a spill, remove all sources of ignition such as open sparks, flames or static discharge to prevent the
ignition of the dust. Minimize dust generation during clean up. Sweep up spill with non-metallic broom and dust pan. Contain for disposal.
Section 7 - Handling And Storage
Store in a cool, dry place.
Section 8 - Exposure Controls/Personal Protection
Exposure Limits:
OSHA (PEL): 5mg/m (dust; respirable dust; PNOR); 15mg/m (dust; total dust; PNOR)
ACGIH (TLV): 5mg/m (iron oxide dust and fume, measured as iron)
Ventilation: Local exhaust ventilation to maintain concentrations below exposure limits
Eye Protection: Safety glasses or goggles
Clothing: None required, coveralls recommended
Gloves: Suitable work gloves such as cotton or leather are recommended
Respirator: Respirator with NIOSH approval for airborne dust at concentrations above exposure limits
Section 9 - Physical And Chemical Properties
Description: Finely divided black powder with faint odor.
Melting Point: Not applicable
Freezing Point: Not applicable
Boiling Point: Not applicable
Pressurized: No
pH: Not applicable
Evaporation Rate: Not applicable
% Volatility: Not applicable
Specific Gravity (H20=1): 1.3
Water Solubility: Negligible
Section 10 - Stability And Reactivity
Stability: Stable
Conditions to Avoid: Ignition sources in combustible atmospheres of
toner dust. Throwing toner into an open fire.
Incompatibilities: Strong oxidizing agents
Hazardous Decomposition: Carbon monoxide, carbon dioxide, low
molecular weight organics
Polymerization: This product will not polymerize.
Section 11 - Toxicology Information
Acute Toxicity: Not expected to be acutely toxic.
Chronic Toxicity: Not expected to be chronically toxic if used with adequate workplace controls. Long term exposure to excessive concentrations of iron
oxide-containing dusts has resulted in an often asymptomatic condition identified as siderosis, a relatively benign pneumoconiosis, caused by deposition of iron
oxide particles in the lung. Ingestion of high doses of insoluble iron salts may result in cardiovascular, liver, and blood component effects.
Section 12 - Ecological Information
No data available
Section 13 - Disposal Information
This product is not a listed or hazardous waste in accordance with Federal Regulation 40 CFR Part 261. If discarded in its purchased form, this product
would not be a hazardous waste either by listing or by characteristic. However, it is the responsibility of the product user to determine at the time of disposal
whether a material has been contaminated and should be classified as a hazardous waste. Disposal is subject to local, state and federal regulations.
Section 14 - Transportation Information
This product is not regulated as a hazardous material by the DOT.
Section 15 - Regulatory Information
All ingredients are registered under the Toxic Substances Control Act (TSCA) or under polymer exemption. All ingredients are exempt, registered or
considered registered (polymers) under European Inventory of Existing Commercial Chemical Substances (EINECS). None of the product ingredients
are listed as Emergency Planning and Community Right-to-Know Act (EPCRA) - Section 302: Extremely Hazardous Substances (EHS).
Components present above the minimum quantities of listed chemicals in EPCRA Section 313 Supplier Notification: This product contains <5 % of a zinc
compound. No ingredients are listed as OSHA, NTP or IARC known or potential carcinogens. This product contains no known materials at levels which the
State of California has found to cause cancer, birth defects or other reproductive harm - California Proposition 65.
Section 16 - Other
Disclaimer: Information is most current known to Lexmark at the time of preparation and is believed to be accurate. No warranty as to its accuracy or
completeness is expressed or implied.
STI-204512
Revised 11/06
Was this manual useful for you? yes no
Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Download PDF

advertising